Esketamine nasal spray in patients with treatment-resistant depression: the real-world experience in the French cohort early-access programme | NobleBlocks
Public
Esketamine nasal spray in patients with treatment-resistant depression: the real-world experience in the French cohort early-access programme
N
Shared by NobleBlocks on Feb 17, 2022 • 12:00 AM UTC
